Skinvisible (SKVI) EV to CFO (2010 - 2026)
Skinvisible's (SKVI) quarterly EV to CFO came in at 523.3 in Q2 2026, up 429.6% year-over-year from 98.81 in Q2 2025, and up 133.21% quarter-over-quarter from 1575.58 in Q1 2026.
Analysis
Skinvisible (SKVI) EV to CFO (2010 - 2026) Analysis & Trends
Skinvisible has disclosed EV to CFO across 17 years of filings, most recently posting 523.3 for Q2 2026.
- In Q2 2026, EV to CFO rose 429.6% year-over-year to 523.3; the TTM figure through Jun 2026 stood at 294.65 (up 1521.06% YoY), while the FY2025 annual figure was 32.29, down 25.46% from the prior year.
- EV to CFO came in at 523.3 for Q2 2026 at Skinvisible, up from 1575.58 in the prior quarter.
- In the past five years, EV to CFO ranged from a high of 1545.67 in Q3 2025 to a low of 1575.58 in Q1 2026.
- Average EV to CFO over 5 years is 7.55, with a median of 26.02 recorded in 2023.
- Year-over-year, EV to CFO jumped 760.89% in 2025 and tumbled 1501.41% in 2026.
- Over 5 years, EV to CFO stood at 8.19 in 2022, then tumbled by 1051.47% to 94.28 in 2023, then dropped by 12.73% to 106.28 in 2024, then jumped by 690.88% to 627.98 in 2025, then slipped by 16.67% to 523.3 in 2026.
- Per Business Quant data, the three most recent EV to CFO figures were 523.3 in Q2 2026, 1575.58 in Q1 2026, and 627.98 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.78 Bn | 626.02 Bn | 17.26 Bn |
| 2 | AbbVie | 439.42 Bn | 432.85 Bn | 12.70 Bn |
| 3 | Merck | 364.63 Bn | 357.49 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.84 Bn | 261.15 Bn | 11.24 Bn |
| 5 | Pfizer | 158.75 Bn | 147.05 Bn | 10.94 Bn |
| 6 | Sanofi | 52.62 Bn | 45.24 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.27 Bn | 44.27 Bn | - |
| 8 | Incyte | 24.99 Bn | 20.45 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.13 Bn | 18.47 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 523.30 |
| Mar 31, 2026 | -1,575.58 |
| Dec 31, 2025 | 627.98 |
| Sep 30, 2025 | 1,545.67 |
| Jun 30, 2025 | -158.77 |
| Mar 31, 2025 | -98.39 |
| Dec 31, 2024 | -106.28 |
| Sep 30, 2024 | -233.88 |
| Jun 30, 2024 | -130.31 |
| Mar 31, 2024 | -25.20 |
| Dec 31, 2023 | -94.28 |
| Sep 30, 2023 | -65.81 |
| Jun 30, 2023 | -26.84 |
| Mar 31, 2023 | -6.46 |
| Dec 31, 2022 | -8.19 |
| Sep 30, 2022 | -19.57 |
| Jun 30, 2022 | 2.34 |
| Mar 31, 2022 | -13.80 |
| Dec 31, 2021 | 6.65 |
| Sep 30, 2021 | 6.81 |